If you missed the two Shockwave IVL sessions at EuroPCR 2021, or would like to watch the symposia again, you’re in luck. The Shockwave IVL content from EuroPCR 2021 is available here.
Welcome to The Catalyst
Change isn't quick. Unless it's when you experience Intravascular Lithotripsy (IVL) for the first time. Stay apprised of our latest news and insights while discovering how a simple and intuitive tool can be The Catalyst to change the way you think about calcium modification.
If you missed the two Shockwave IVL sessions at EuroPCR 2021, or would like to watch the symposia again, you’re in luck. The Shockwave IVL content from EuroPCR 2021 is available here.
Topics: Coronary Clinical Data, Shockwave C2, Coronary Conferences
PulsePoint is back! Bringing you a highlight reel of the most memorable moments, successes and key events of Q1 for both our coronary and peripheral technology. Most notably, Shockwave had a history-making moment in February of this year when we received FDA approval in the U.S. for Coronary IVL! Since then, we have seen many physicians achieving great success utilizing the technology. We also brought a new podcast, ChalkTalk, to life, and so much more we want to share with you. Check out the latest PulsePoint for the full scoop!
Topics: Coronary IVL, Peripheral IVL, IVL Technology, PulsePoint Newsletter
We had the privilege of connecting with Dr. Robert Riley Director, Complex Coronary Therapeutics Program, The Christ Hospital Health System. Dr. Riley is the leading author of the abstract for the Patient-Level Pooled Analysis of the Disrupt CAD I, II, III and IV studies and presented at ACC.21 Virtual.
Topics: Coronary IVL, Coronary Clinical Data, Shockwave C2, Coronary Conferences
You know the expression – “the more things change, the more they stay the same.” Well if there’s anything that we learned over the last year, it’s that this phrase absolutely does not apply to anything related to IVL.
Topics: Coronary Clinical Data, Shockwave C2, Coronary Conferences
From Data to Daily Practice; Disrupting Calcium with IVL across multiple vessel beds.
Topics: Peripheral IVL, Peripheral Conferences, Peripheral Clinical Data
Shockwave is in the midst of preparing to go direct in the UK on 1st of July.
Topics: IVL Technology, SWAV News
One cannot become a calcium expert overnight – it takes time and commitment to go deep on the topic. That’s why we’re excited to embark this month on a year-long education journey that we’re calling the Calcium Masterclass. Over the last year, we’ve been working with Prof. James Spratt (St. George’s University, London) and the team at Optima Education to develop a comprehensive collection of 10 webinars, 5 of which will feature live cases, and a 14-chapter calcium compendium that will be presented by 37 masters of coronary calcium.
Topics: Coronary IVL, Shockwave C2
IVL use in real world CFA population shows low residual stenosis and 0% complications.
Topics: Peripheral IVL
Recently, SCAI presented a Complex PCI webinar that featured world renowned panelists sharing the latest SCAI guidelines for calcified lesions, which included newly approved coronary IVL.
Topics: Coronary IVL
Welcome to ChalkTalk, our new podcast series where we discuss all things cardiovascular calcium, featuring perspective from our leaders and leading physicians who are using IVL in clinical practice to crack their toughest cases. We plan to bring you the latest cases, insights & evidence surrounding both coronary and peripheral Shockwave IVL.
Topics: Coronary IVL, Peripheral IVL, IVL Technology, SWAV News, ChalkTalk Podcast
But, right now we're in the early phases of the R&D program. In the meantime, don't miss the IVL application that heart teams are embracing already — maintaining transfemoral TAVR access through heavily calcified iliacs by using IVL.
